» Articles » PMID: 34983468

Urinary Manifestations in African American and Caucasian Inflammatory Bowel Disease Patients: a Retrospective Cohort Study

Overview
Journal BMC Urol
Publisher Biomed Central
Specialty Urology
Date 2022 Jan 5
PMID 34983468
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inflammatory bowel diseases (IBD), like ulcerative colitis (UC) and Crohn's disease (CD), are associated with urinary extra-intestinal manifestations, like urolithiasis and uncomplicated urinary tract infections (UTIs). The literature reviewed for this study identifies an increased association of CD and urolithiasis against the general population as well as UC. Furthermore, the rates in which urinary comorbidities manifest have not been well characterized in cross-race analyses. The purpose of this study is to establish the prevalence of common urinary extra-intestinal manifestations in CD and UC and to further determine at what rate these affect the African American and Caucasian populations.

Methodology: This is a retrospective cohort study using de-identified data collected from a research data base that included 6 integrated facilities associated with one tertiary healthcare center from 2012 to 2019. The electronic chart records for 3104 Caucasian and African American IBD patients were reviewed for frequency of urolithiasis and uncomplicated UTI via diagnosed ICD-10 codes. Comparison between data groups was made using multivariate regressions, t-tests, and chi square tests.

Results: Our study included 3104 patients of which 59% were female, 38% were African American, and 43% were diagnosed with UC. Similar proportions of UC and CD diagnosed patients developed urolithiasis (6.0% vs 6.7%, p = 0.46), as well as uncomplicated UTIs (15.6% vs. 14.9%, p = 0.56). Similar proportions of African American and Caucasian patients developed urolithiasis (5.4% vs 7.0%, p = 0.09), but a higher proportion of African Americans developed uncomplicated UTIs (19.4% vs 12.6%, p ≤ 0.001).

Conclusion: We found similar rates of urolithiasis formation in both UC and CD in this study. Furthermore, these rates were not significantly different between African American and Caucasian IBD populations. This suggests that UC patients have an elevated risk of urolithiasis formation as those patients with CD. Additionally, African Americans with IBD have a higher frequency of uncomplicated UTI as compared to their Caucasian counterparts.

Citing Articles

Dual-Stage AI Model for Enhanced CT Imaging: Precision Segmentation of Kidney and Tumors.

Karunanayake N, Lu L, Yang H, Geng P, Akin O, Furberg H Tomography. 2025; 11(1).

PMID: 39852683 PMC: 11769543. DOI: 10.3390/tomography11010003.


The effect of calcium oxalate stones and uric acid stones on male sexual function.

Chen J, Pang N, Lu J, Liu G, Lee S, Wang W Int Urol Nephrol. 2024; 57(1):19-25.

PMID: 38958853 DOI: 10.1007/s11255-024-04127-0.


Sleep and circadian rhythm disturbance in kidney stone disease: a narrative review.

He S, Wang J, Li T, Yin S, Cui J, Xiao Y Front Endocrinol (Lausanne). 2023; 14:1293685.

PMID: 38089624 PMC: 10711275. DOI: 10.3389/fendo.2023.1293685.


Urolithiasis in patients with inflammatory bowel disease: A systematic review and meta-analysis of 13,339,065 individuals.

Abdulrhman A, Alsweed A, Alotaibi M, Aldakhil A, Alahmadi S, Albishri S Medicine (Baltimore). 2023; 102(24):e33938.

PMID: 37327280 PMC: 10270553. DOI: 10.1097/MD.0000000000033938.


Phylogrouping and characterization of isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran.

Nadalian B, Nadalian B, Houri H, Shahrokh S, Abdehagh M, Yadegar A Front Med (Lausanne). 2022; 9:985300.

PMID: 36106322 PMC: 9464868. DOI: 10.3389/fmed.2022.985300.


References
1.
Simsek M, de Boer N . Mesalazine and Nephrolithiasis: Leave No Stone Unturned. Am J Gastroenterol. 2019; 114(8):1359-1360. DOI: 10.14309/ajg.0000000000000311. View

2.
MARATKA Z, Nedbal J . UROLITHIASIS AS A COMPLICATION OF THE SURGICAL TREATMENT OF ULCERATIVE COLITIS. Gut. 1964; 5:214-7. PMC: 1552125. DOI: 10.1136/gut.5.3.214. View

3.
Varda B, McNabb-Baltar J, Sood A, Ghani K, Kibel A, Letendre J . Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. Urology. 2015; 85(4):764-70. DOI: 10.1016/j.urology.2014.12.011. View

4.
Corica D, Romano C . Renal Involvement in Inflammatory Bowel Diseases. J Crohns Colitis. 2015; 10(2):226-35. DOI: 10.1093/ecco-jcc/jjv138. View

5.
Larsen S, Bendtzen K, Nielsen O . Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010; 42(2):97-114. DOI: 10.3109/07853890903559724. View